Connect Biopharma (CNTB) Analyst & Key Data

Analyst Consensus

Buy7 analysts

Buy

Updated Sep 12, 2026

Total Analysts7

Buy

5

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.04

Median Target+236.27%

$6.86

Potential upside vs current price

DCF Value-67.94%

$0.65

Potential downside vs current price

Current Stock Price

$2.04

Median Target+236.27%

$6.86

Potential upside vs current price

DCF Value-67.94%

$0.65

Potential downside vs current price

Analyst Consensus

Buy7 analysts

Buy

Updated Sep 12, 2026

Total Analysts7

Buy

5

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.04

Median Target+236.27%

$6.86

Potential upside vs current price

DCF Value-67.94%

$0.65

Potential downside vs current price

Current Stock Price

$2.04

Median Target+236.27%

$6.86

Potential upside vs current price

DCF Value-67.94%

$0.65

Potential downside vs current price

Connect Biopharma Holdings Limited